Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Fieser Dairy, Inc.
WARNING LETTER
•Fieser Dairy, Inc.•November 17, 2011

FDA WARNING_LETTER - Fieser Dairy, Inc. - November 17, 2011

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On November 16 and 17, 2011, the FDA inspected Fieser Dairy, Inc., identifying violations of the Federal Food, Drug, and Cosmetic Act. The firm offered for sale adulterated animals for slaughter. Specifically, two dairy cows sold on August 15, 2011, and slaughtered on August 16, 2011, contained sulfamethazine residues in liver and muscle tissue (0.134 ppm and 0.063 ppm in one, 0.245 ppm and 0.076 ppm in the other), for which FDA has no established tolerance in lactating dairy cattle. This violates 21 U.S.C. § 342(a)(2)(C)(ii).

The investigation also found insanitary conditions, including a failure to maintain complete treatment records, making it likely that medicated animals with harmful drug residues could enter the food supply, violating 21 U.S.C. § 342(a)(4).

Furthermore, the firm adulterated new animal drugs, including chlortetracycline plus sulfamethazine and decoquinate medicated feeds, by using them extra-label without veterinary oversight and not as directed by approved labeling. This included administering an unapproved combination of drugs in animal feeds, not following specified duration of treatment, withdrawal periods, or animal class. Specific violations include extralabel use

Company
Fieser Dairy, Inc.
Inspection Date
November 17, 2011
Product Type
Drugs
Office
Florida District Office
People
  • Emma R. Singleton (District Director)
  • Ronnie E. Jackson (Retired Former Director of Compliance)
Open in Dashboard

ID · 02927668-49aa-47ac-941f-be9c6fa90343

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 53021 CFR 530.11(b)21 CFR 558.14021 CFR 558.195

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.